Page 3 - Kolon Life Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kolon life science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kolon Life Science Today - Breaking & Trending Today

BIO KOREA 2021 International Convention to Unlock the Secret of Future Technologies


BIO KOREA 2021 International Convention to Unlock the Secret of Future Technologies
Thursday, May 27, 2021 4:00PM IST (10:30AM GMT)
 
Seoul, South Korea:
 
As one of the most important global bio-health conventions, BIO KOREA 2021 International Convention has garnered great attention from home and abroad. To facilitate the discussion on the future bio-health industry in the ‘COVID-19 era’, the BIO KOREA 2021 to be held on June 9 to 21 will evolve around the theme of “New Normal: Breaking Barriers with Bio Innovation”.
 
BIO KOREA organizing committee announced the main programs, deep-diving into business strategies in the post-pandemic era.
 
The Four Programs Focusing on Biohealth Industry and Business ....

Soult Ukpyolsi , South Korea , Shinpoong Pharm , Chong Kun Dang , Digital Health , International Convention , Business Forum , Drug Development , Breaking Barriers , Four Programs Focusing , Biohealth Industry , Kolon Life Science , Biot Korea , Digital Healthcare Themed , Digital Wellness , Mobile Healthcare , Digital Therapeutics , Big Data , Media Contact , Bio Korea Organizing Committee , Io Korea 2021 , International Convention , Future Technologies , Io Health Conventions , Rio Innovation , Business Forum ,

Kolon Life executives acquitted of falsifying data of gene therapy drug


Kolon Life executives acquitted of falsifying data of gene therapy drug
Posted : 2021-02-19 15:39
Updated : 2021-02-19 17:08
Kolon Life Science s Invossa, a cell and gene therapy for osteoarthritis. Courtesy of Kolon Life ScienceTwo Kolon Life Science executives were acquitted Friday of involvment in the company s allegedly fraudulent report on a key ingredient in its gene therapy drug.
The Seoul Central District Court handed down the ruling to the drugmaker s two executives, surnamed Cho and Kim, who were indicted on charges including fraud related to the company s suspected illegalities in the development and sales of Invossa, a cell and gene therapy for osteoarthritis. ....

Soult Ukpyolsi , South Korea , Kolon Group , Seoul Central District Court , Ministry Of Food , Kolon Life Science , Kolon Life , Life Science , Drug Safety , தெற்கு கொரியா , சியோல் மைய மாவட்டம் நீதிமன்றம் , அமைச்சகம் ஆஃப் உணவு , வாழ்க்கை அறிவியல் , மருந்து பாதுகாப்பு ,